Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

JAK inhibitors show promise in treating difficult skin diseases.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Inflammation in psoriasis may trigger antimicrobial peptides and cell death.

JAK inhibitors show promise for treating various skin diseases.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.